Citadel's motion to dismiss has now been denied in NWBO case

Citadel's motion to dismiss has now been denied in NWBO case

In a noteworthy development in the ongoing legal battle involving Northwest Biotherapeutics, Inc. (“NWBO”), the Court has denied a motion by the defendants, which include Citadel and six other brokers, to dismiss the case based on allegations of market manipulation through a practice known as “spoofing.” This ruling reflects a significant victory for the plaintiff as it allows certain allegations to proceed in court while highlighting the comple…